H.R. 1676, Jack Reynolds Memorial Medigap Extension Act;
H.R. 1255/S. 377, The Living Donor Protection Act of 2021;
H.R. 4065, The Chronic Kidney Disease Improvement in Research and Treatment Act;
S. 1971, Chronic Kidney Disease Improvement in Research and Treatment Act of 2021;
Direct distribution of COVID-19 vaccines to dialysis facilities by HHS;
Implementation of Executive Order 13879, Advancing American Kidney Health. H.R. 1676, Jack Reynolds Memorial Medigap Extension Act; 
Issues related to Medicare Part D coverage for drugs indicated to treat patients with chronic kidney disease;
H.R. 2934, Renal Anemia Innovation Support and Expansion (RAISE) Act
H.R. 4065, The Chronic Kidney Disease Improvement in Research and Treatment Act;
S. 1971, Chronic Kidney Disease Improvement in Research and Treatment Act of 2021;
CY 2022 Medicare End Stage Renal Disease (ESRD) Prospective Payment System (PPS) and Quality Improvement Program (QIP) rule making;
CY 2022 policy and technical issues changes to the Medicare Advantage Program and Medicare Prescription Drug Benefit Program;
Centers for Medicare and Medicaid Innovation (CMMI) ESRD Treatment Choices (ETC) model;
Implementation of expanded Medicare immunosuppressive drug coverage for kidney transplant patients;
Implementation of Executive Order 13879, Advancing American Kidney Health;
Telehealth flexibilities for nephrologists and kidney patients on dialysis.
HCR - Health Issues MMM - Medicare/Medicaid
136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
AKEBIA THERAPEUTICS, INC.
245 First Street, Suite 1100, Cambridge, MA, 02142, US
SARA FROELICH SARA FROELICH